Skip to Content
Sci. Pharm.Scientia Pharmaceutica
  • Scientia Pharmaceutica is published by MDPI from Volume 84 Issue 3 (2016). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Austrian Pharmaceutical Society (Österreichische Pharmazeutische Gesellschaft, ÖPhG).
  • Article
  • Open Access

23 September 2008

Spectral Characterization of Degradation Impurities of Paroxetine Hydrochloride Hemihydrate

,
,
,
,
and
1
Department of Analytical Research, Discovery Research, Dr. Reddy’s Laboratories, Bollaram Road, Miyapur, Hyderabad 500 049, India
2
Research and development, Dr. Reddy’s Laboratories Ltd., Integrated Product Development, Unit-III, Plot No.116, S.V. Co-Op.Indl. Estate, Bollaram, Jinnaram, Medak-502 325, India
3
Jawaharlal Nehru Technological University, Kukatpally, Hyderabad-500 072, India
*
Author to whom correspondence should be addressed.

Abstract

Two unknown impurities were detected in stressed samples (by hydrochloric acid and hydrogen peroxide) of paroxetine hydrochloride hemihydrate (an active pharmaceutical ingredient – API) using a gradient reversed-phase high performance liquid chromatography (HPLC). These impurities were enriched and were present up to 30% in the degraded sample. The impurities were isolated from the degraded sample by column purification. Spectral data of the isolated impurities were collected. Based on the spectral data of two dimensional nuclear magnetic spectroscopy (2D-NMR) and mass spectrometry (MS) Impurity-1 and Impurity-2 were characterized as (3S,4R)-3-{[(6-chloro-1,3-benzodioxol-5-yl)oxy]methyl}-4-(4-fluorophenyl)piperidine and [(3S,4R)-4-(4-fluorophenyl)piperidin-3-yl]methanol respectively.

Article Metrics

Citations

Article Access Statistics

Multiple requests from the same IP address are counted as one view.